UK Industry Calls For 'Early & Open' Talks Over ‘Extreme’ 2023 Clawbacks

The current UK approach to drug pricing and access is "broken," and early talks with the government next year will be necessary to set out a "completely new future settlement," the pharmaceutical industry has warned. By contrast, the government claims that the pricing scheme is working as intended.